HeartFlow, Inc

Attending MedAxiom’s CV Transforum? Join us this Friday, October 18th at 7:15am in Red Rock 4&5 (in-person or virtually) to learn how two health systems leveraged best practices to implement and scale their CCTA + HeartFlow programs across their hospitals.

HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024. Six presentations will be discussed to build upon the growing body of rigorous clinical evidence supporting non-invasive FFRCT technology and plaque analysis in the diagnosis and management of coronary artery disease. Learn more here: https://bit.ly/3Yr0YZB. #HeartFlow #TCT2024

We’re proud to see #HeartFlow featured on national Italian TV for its role at the Monzino Cardiology Center (Centro Cardiologico Monzino). Under the expertise of Prof. Gianluca Pontone, MD, PhD our non-invasive FFRct Analysis combined with advanced cardiac CT imaging is enabling clinicians to gain precise, detailed insights into coronary artery disease. This approach is reducing the need for invasive procedures and enhancing patient care by minimizing radiation exposure and delivering highly accurate diagnostics. Catch the full story on Tgcom24: https://bit.ly/3Nr62b0.

Later this month, HeartFlow will be attending #TCT2024 from October 27-30 in Washington DC. Will you be attending? We’ll be hosting live sessions presenting exciting clinical data, a lunch symposium and will have experts located at our booth to connect with. You won’t want to miss out! Fill out this form and connect with us: https://bit.ly/47TusDH. #HeartFlow #CAD #yesCCT #FFRCT

Are lesion-specific FFRCT values important in the non-invasive assessment of coronary artery disease? Hear from leading experts Drs. Mark Rabbat and Jonathon Leipsic as they discuss the benefits of utilizing lesion-specific physiology for multivessel disease case planning. Watch the video on VuMedi here: https://bit.ly/3WHPjpk. #HeartFlow #FFRCT #CCTA #AI #heartcare

Join @PraveenRangana9 and Dr. Bon-Kwon Koo as they dive into groundbreaking research on coronary physiology, plaque morphology, and culprit lesion identification in the EMERALD and EMERALD II studies. This episode is sponsored by HeartFlow, Inc. https://ow.ly/uiJo50TJQlt

Today, we’re celebrating a monumental step forward in cardiac care. Medicare has released HeartFlow Plaque Analysis coverage for eligible patients with coronary artery disease (CAD-RADS 1-3). This means more patients can receive personalized, precise care based on the true extent of their coronary plaque. Learn more about this milestone achievement and its impact on patient care: https://bit.ly/4dOLIv0. #HeartFlow #HeartFlowPlaqueAnalysis #Plaque #Medicare

We're honored to award Geisinger Medical Center Danville on their first CT Quality win for Q2 2024. The CT imaging team pictured here is committed to providing quality care to their patients in the Danville, PA area. Congratulations on being amongst the top 19% of medical centers providing patients with a better pathway for understanding their heart health.

Join us at #TCT2024 on Tuesday, October 29th for a special lunch in the FDA Theater! Drs. Ziad Ali, Nick Curzen, Akiko Maehara, Suzanne Baron, and Jimmy Kerrigan will discuss the role of Coronary CTA & HeartFlow. Be part of the conversation! #HeartFlow #FFRCT #yesCCT

HeartFlow will be at #TCT2024 later this month, will you be there? Stay tuned for more information on HeartFlow activities in DC. We’re eager to connect with you and showcase exciting data backing our technology. Fill out this form if you’re interested in speaking to an expert on how we’re revolutionizing precision heart care: https://bit.ly/47TusDH. #HeartFlow #CAD #yesCCT #FFRCT